
Sign up to save your podcasts
Or
Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
5
11 ratings
Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
30,219 Listeners
6,369 Listeners
68,690 Listeners
1,786 Listeners
2,806 Listeners
2,538 Listeners
2 Listeners
16 Listeners
23 Listeners
8,685 Listeners
602 Listeners
12,115 Listeners
15,263 Listeners